For example, we continue to explore the potential of BRIUMVI in MG and have treated a small number of patients with ...
A discussion of why we use non-GAAP financial measures and information regarding reconciliation of our GAAP versus non-GAAP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback